A month has gone by since the last earnings report for Pfizer (PFE). Shares have added about 3.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...
Zacks Investment Research on MSN
Pfizer (PFE) outpaces stock market gains: What you should know
In the latest close session, Pfizer (PFE) was up +1.12% at $25.18. The stock outpaced the S&P 500's daily gain of 0.19%. Meanwhile, the Dow experienced a rise of 0.66%, and the technology-dominated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback